Mission Bay Capital

Mission Bay Capital

Mission Bay Capital is a venture capital firm investing in early stage biotechnology and life science companies. It is headquartered in San Francisco and was founded in 2009 by the California Institute of Quantitative Biosciences.

The California Institute of Quantitative Biosciences (QB3) founded Mission Bay Capital in 2009 to provide venture capital to startups at the University of California. Mission Bay Capital is a venture capital firm making seed and early stage investments in startup technology companies typically operating within the industries of biotechnology and life science. The firms head office is located in San Francisco, California. Notable exits made by Mission Bay Capital include: Calithera Biosciences, iPierian, Redwood Bioscience, and Zephyrus Biosciences.

Timeline

Funded Companies

Company
Description
Industry
Website
Location
Bolt Threads

Bolt Threads is a biotechnology company that makes high performance fabrics and materials using biology.

Caribou Biosciences is a Berkeley California based private company founded in 2011 by Jennifer Doudna and Rachel Haurwitz based on CRISPR technology.

A biotechnology company founded in 2015 which operates as a subsidiary of Gilead Sciences and Kite Pharma. The company developed a platform for custom cell engineering called synNotch to be used for anticancer therapies. Their system can also be used to develop cell-based therapies for autoimmune and degenerative disorders.

Wild Type is a San Francisco based company producing meat products like salmon using cellular agriculture lab techniques.

Biotechnology company developing cell permeable macrocyclic peptide therapeutics using an automated chemistry synthesis.

Pionyr Immunotherapeutics is a San Francisco-based biotechnology company and developer of cancer immunotherapies designed to target the tumor microenvironment.

SiteOne Therapeutics is a Bozeman, Montana-based developer of products for therapeutics and diagnostics.

A biopharmaceutical company developing oral small molecule therapies for the treatment of cancer and autoimmune diseases

A company dedicated on the discovery and development of small molecule therapeutics to treat cancer

Alector is a San Francisco-based biotechnology company.

GraphWear Technologies is a San Francisco-based company.

ViewPoint Therapeutics is a San Francisco-based company.

12 Results
Page 1 of 1
Results per page:
Powered by Golden Research Engine

Associated investment funds

Investment Fund
Total offering (USD)
Total sold (USD)
Location
Date signed
Mission Bay Capital II, L.P.
25,000,000
25,000,000
May 2, 2015
15,000,000
6,053,873
September 1, 2009
85,000,000
26,271,034
August 8, 2018
3 Results
Page 1 of 1
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn

Brian Atwood

Investment Committee

Brook Byers

Investment Committee

Chris Christoffersen

Investment Committee

Douglas Crawford

Managing Director

Fred Cohen

Investment Committee

Harold E. Selick

Venture Partner

John Wadsworth, Jr

Investment Committee

Jonathan Root

Investment Committee

Linda Eng

Office Manager

Luke Evnin

Investment Committee

Peter D. Parker

Managing General Partner

Regis Kelly

Senior Advisor

Robert Blazej

Partner

Vivian Dang

Controller

Wende Hutton

Investment Committee

Further reading

Title
Author
Link
Type
Date

Mission Bay Capital Fund Launches - PE Hub

OEHub Administrator

Web

Mission Bay Capital Raising $85 Million for Life Science Startups

Heather Mack

Web

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

Alector

Genomics/Medical

Agriculture

Medical/Immunotherapy

Medical/Gastrointestinal Disorders

Fashion/Cellular Agriculture/Biotechnology

Biotechnology

Medical/Neurological Disorders

Drug Development

Health Monitoring

Genomics/Medical

Medical

Medical/Drug Discovery

Health Monitoring

Health Monitoring

Medical

Disease Detection

Medical

Drug Discovery

Scientific Research Tools

Biopharmaceuticals

Page 1 of 2

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.